Shares in Bruker Decline 11 Percent After Firm Said Material Weakness Will Raise 04 Losses

Mar 16, 2005

NEW YORK, March 16 (GenomeWeb News) - Shares in Bruker Biosciences were down more than 11 percent, or $.44, at $3.51 in mid-afternoon trading after the firm said that its 2004 net losses, reported on March 2, would likely increase following internal audits.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Main menu